MX2021013888A - Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas. - Google Patents

Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas.

Info

Publication number
MX2021013888A
MX2021013888A MX2021013888A MX2021013888A MX2021013888A MX 2021013888 A MX2021013888 A MX 2021013888A MX 2021013888 A MX2021013888 A MX 2021013888A MX 2021013888 A MX2021013888 A MX 2021013888A MX 2021013888 A MX2021013888 A MX 2021013888A
Authority
MX
Mexico
Prior art keywords
ephedrine
making
methods
same
compositions
Prior art date
Application number
MX2021013888A
Other languages
English (en)
Inventor
Shahid Ahmed
Original Assignee
Nexus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73230956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2021013888(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nexus Pharmaceuticals Inc filed Critical Nexus Pharmaceuticals Inc
Publication of MX2021013888A publication Critical patent/MX2021013888A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Abstract

La presente descripción proporciona composiciones que comprenden sulfato de efedrina listas para el uso inmediato en un entorno clínico, y métodos de fabricación y uso de las mismas.
MX2021013888A 2019-05-16 2020-05-16 Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas. MX2021013888A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962849125P 2019-05-16 2019-05-16
PCT/US2020/033310 WO2020232424A1 (en) 2019-05-16 2020-05-16 Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Publications (1)

Publication Number Publication Date
MX2021013888A true MX2021013888A (es) 2022-01-24

Family

ID=73230956

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013888A MX2021013888A (es) 2019-05-16 2020-05-16 Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas.

Country Status (10)

Country Link
US (7) US11090278B2 (es)
EP (1) EP3968975A4 (es)
JP (2) JP2022532657A (es)
KR (1) KR20220009985A (es)
CN (1) CN113825500A (es)
AU (1) AU2020276619A1 (es)
CA (1) CA3140043A1 (es)
IL (1) IL288044A (es)
MX (1) MX2021013888A (es)
WO (1) WO2020232424A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) * 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods
US20230172840A1 (en) 2021-12-05 2023-06-08 Fresenius Kabi Austria Gmbh Ephedrine liquid formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
FR2890316B1 (fr) 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
FR2896168B1 (fr) 2006-01-19 2008-10-17 Aguettant Soc Par Actions Simp Seringue hypodermique preremplie equipee d'un dispositif de bouchage
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
FR2992222B1 (fr) 2012-06-22 2015-06-19 Aguettant Lab Dispositif de protection destine a equiper un dispositif d’injection pourvu d’un embout de raccordement
ES2770731T3 (es) * 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
FR3053893B1 (fr) 2016-07-13 2018-07-27 Laboratoire Aguettant Dispositif medical comportant un emballage et une seringue pre-remplie disposee dans l’emballage
WO2018140894A1 (en) * 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor
WO2019177725A1 (en) 2018-03-13 2019-09-19 Nevakar Inc. Prefilled syringe, compositions and methods
FR3084263B1 (fr) 2018-07-27 2020-07-10 Laboratoire Aguettant Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture
JP2022532657A (ja) 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法
US10869845B1 (en) 2020-01-22 2020-12-22 Nevakar Inc. Ephedrine compositions and methods

Also Published As

Publication number Publication date
US20220257539A1 (en) 2022-08-18
US20230068187A1 (en) 2023-03-02
EP3968975A4 (en) 2023-02-15
US20210353561A1 (en) 2021-11-18
US20210393552A1 (en) 2021-12-23
US11090278B2 (en) 2021-08-17
US11478436B2 (en) 2022-10-25
WO2020232424A1 (en) 2020-11-19
US20220265580A2 (en) 2022-08-25
CN113825500A (zh) 2021-12-21
US20230025407A1 (en) 2023-01-26
JP2023091072A (ja) 2023-06-29
JP2022532657A (ja) 2022-07-15
US11426369B2 (en) 2022-08-30
US20200360309A1 (en) 2020-11-19
IL288044A (en) 2022-01-01
US11464752B2 (en) 2022-10-11
US20220110892A1 (en) 2022-04-14
US11571398B1 (en) 2023-02-07
EP3968975A1 (en) 2022-03-23
KR20220009985A (ko) 2022-01-25
AU2020276619A1 (en) 2021-12-16
CA3140043A1 (en) 2020-11-19
US11241400B2 (en) 2022-02-08

Similar Documents

Publication Publication Date Title
MX2021013888A (es) Composiciones que comprenden efedrina o una sal de efedrina y metodos de fabricacion y uso de las mismas.
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX2017016655A (es) Formulaciones oftalmicas de inhibidores de tirosina quinasa, metodos de uso de las mismas y metodos de preparacion de las mismas.
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
IL288997A (en) Salt forms of Bampedoic acid and methods of using them
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MX2020006612A (es) Compuesto que funciona como inhibidor de proteína de bromodominio y composición.
MX2018004509A (es) Anticuerpos anti-htra1 y metodos de uso de los mismos.
MY192532A (en) Liquid pharmaceutical composition
PH12020551716A1 (en) Anti-ror antibody constructs
MX2020001875A (es) Forma polimorfica de tg02.
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
ZA201907520B (en) Stable liquid formulations of prothioconazole
EP3936509A4 (en) FGFR4 KINASE INHIBITOR, METHOD FOR PREPARATION AND USE
MX2022003212A (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso.
MX2021014206A (es) Oligonucleotidos gapmer modificados y metodos de uso.
EP3677126A4 (en) COMPOSITION OF AGE INHIBITORS, ITS USE, PROCESS OF PREPARATION AND ITS FORMULATION
AU2018262805A1 (en) Peptides for treatment of diabetes
PH12021550413A1 (en) Vitamin d pediatric dosage forms, methods of making and using
EP3984361A4 (en) PLANT ACTIVATOR WITH AN AMINO ACID OR A SALT THEREOF AND OLIGOSACCHARIDE AND USE THEREOF
MX2021013913A (es) Composiciones y metodos para el tratamiento de enfermedades mediadas por atpasa.
MX2020011027A (es) Constructos de anticuerpos biespecíficos trivalentes.
WO2019213606A3 (en) Solid forms of cerdulatinib
PH12016502386A1 (en) Oral care compositions
MX2018004296A (es) Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada.